Sharon Benzeno, Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp (ADPT), sold 165,802 shares at $21.00 ($3.5M) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($3.5M) by Chief Commercial Ofc Imm Med under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.00 | 11,034 | $232K | 6.6% |
| 2 | $21.14 | 154,768 | $3.3M | 93.4% |
| Total | $21.13 avg | 165,802 | $3.5M | 100% |
| Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |
| ADPT | SELL | 2024-03-06 | $165K | — | Filing → |